Cargando…
Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
PURPOSE: To present the molecular mechanisms involved in the pathogenesis of conjunctival melanoma (CM) and review the existing literature on targeted molecular inhibitors as well as immune checkpoint inhibitors for the management of locally advanced and metastatic disease. METHODS: A comprehensive...
Autores principales: | Gkiala, Anastasia, Palioura, Sotiria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553763/ https://www.ncbi.nlm.nih.gov/pubmed/33116365 http://dx.doi.org/10.2147/OPTH.S271569 |
Ejemplares similares
-
Intraocular Invasion of Ocular Surface Squamous Neoplasia Through a Corneal Wound
por: Laura, Diana M., et al.
Publicado: (2020) -
Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
por: Sa, Ho-Seok, et al.
Publicado: (2022) -
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019) -
Genetic Aspects of Conjunctival Melanoma: A Review
por: Chang, Emily, et al.
Publicado: (2023) -
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted Therapies
por: Rubanov, Andrey, et al.
Publicado: (2022)